Rating History for TCR2 Therapeutics (TCRR) by Goldman Sachs

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/19/2022 Madhu Kumar New Coverage Neutral
(N/A)
5.00
(N/A)
4.01
(2.89)
-27.93% Details